PCOLCE
Basic information
Region (hg38): 7:100602363-100608175
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PCOLCE gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 28 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 2 | 1 |
Variants in PCOLCE
This is a list of pathogenic ClinVar variants found in the PCOLCE region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-100602473-C-G | not specified | Uncertain significance (Oct 07, 2024) | ||
7-100602476-C-A | not specified | Uncertain significance (Sep 22, 2023) | ||
7-100602528-G-C | not specified | Uncertain significance (Nov 22, 2023) | ||
7-100603459-A-T | not specified | Uncertain significance (Nov 13, 2024) | ||
7-100603466-A-T | not specified | Uncertain significance (Jul 25, 2024) | ||
7-100603509-C-G | not specified | Uncertain significance (Mar 29, 2022) | ||
7-100603513-A-G | not specified | Uncertain significance (Mar 12, 2024) | ||
7-100603526-C-G | not specified | Uncertain significance (Dec 08, 2023) | ||
7-100603966-A-G | not specified | Uncertain significance (Jan 03, 2024) | ||
7-100604010-C-A | not specified | Uncertain significance (Jan 26, 2022) | ||
7-100604016-C-G | not specified | Uncertain significance (Jan 24, 2024) | ||
7-100604046-T-C | not specified | Uncertain significance (Jan 06, 2023) | ||
7-100604059-G-C | not specified | Uncertain significance (Oct 21, 2021) | ||
7-100604128-A-G | not specified | Uncertain significance (Sep 17, 2021) | ||
7-100605094-A-G | not specified | Uncertain significance (Feb 07, 2025) | ||
7-100605117-G-A | not specified | Uncertain significance (Jan 03, 2025) | ||
7-100605182-C-G | not specified | Uncertain significance (Oct 22, 2021) | ||
7-100605208-C-G | not specified | Likely benign (Jan 02, 2024) | ||
7-100605679-A-T | not specified | Uncertain significance (Apr 08, 2024) | ||
7-100605757-G-T | not specified | Uncertain significance (Jan 17, 2025) | ||
7-100605785-G-A | not specified | Uncertain significance (Feb 01, 2025) | ||
7-100605805-G-A | not specified | Uncertain significance (Dec 25, 2024) | ||
7-100606444-C-T | not specified | Uncertain significance (Nov 26, 2024) | ||
7-100606512-G-A | PCOLCE-related disorder | Likely benign (Aug 06, 2019) | ||
7-100606513-C-A | PCOLCE-related disorder | Likely benign (Aug 06, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PCOLCE | protein_coding | protein_coding | ENST00000223061 | 9 | 5999 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000584 | 0.975 | 125730 | 0 | 17 | 125747 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.160 | 256 | 263 | 0.972 | 0.0000142 | 2828 |
Missense in Polyphen | 90 | 97.372 | 0.92429 | 1127 | ||
Synonymous | -1.05 | 130 | 116 | 1.12 | 0.00000649 | 966 |
Loss of Function | 2.02 | 10 | 19.6 | 0.509 | 8.52e-7 | 224 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000647 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000801 | 0.0000791 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.0000660 | 0.0000653 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to the C-terminal propeptide of type I procollagen and enhances procollagen C-proteinase activity.;
- Pathway
- Crosslinking of collagen fibrils;Assembly of collagen fibrils and other multimeric structures;Collagen biosynthesis and modifying enzymes;Collagen formation;Extracellular matrix organization
(Consensus)
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- loftool
- 0.580
- rvis_EVS
- -0.13
- rvis_percentile_EVS
- 43.91
Haploinsufficiency Scores
- pHI
- 0.758
- hipred
- Y
- hipred_score
- 0.580
- ghis
- 0.596
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.215
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pcolce
- Phenotype
- limbs/digits/tail phenotype; muscle phenotype; skeleton phenotype;
Gene ontology
- Biological process
- proteolysis;multicellular organism development;positive regulation of peptidase activity;cellular response to leukemia inhibitory factor
- Cellular component
- extracellular region;extracellular space;collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- extracellular matrix structural constituent;protein binding;collagen binding;heparin binding;peptidase activator activity